FDMT

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

4D Molecular Therapeutics Inc

NASDAQ | FDMT

9.84

USD

$0.00

(

0.00%

)

At Close (As of Oct 17, 2025)

$471.23M

Market Cap

-

P/E Ratio

-3.53

EPS

$10.73

52 Week High

$2.23

52 Week Low

HEALTHCARE

Sector

FDMT Chart

Recent Chart
Price Action

FDMT Technicals

Tags:

FDMT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $37K
Total Revenue $37K
Cost Of Revenue $6.7M
Costof Goods And Services Sold $6.7M
Operating Income -$188M
Selling General And Administrative $47M
Research And Development $141M
Operating Expenses $188M
Investment Income Net -
Net Interest Income $27M
Interest Income $27M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.7M
Income Before Tax -$161M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$161M
Comprehensive Income Net Of Tax -
Ebit -$195M
Ebitda -$188M
Net Income -$161M

Revenue & Profitability

Earnings Performance

FDMT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $560M
Total Current Assets $435M
Cash And Cash Equivalents At Carrying Value $149M
Cash And Short Term Investments $149M
Inventory -
Current Net Receivables -
Total Non Current Assets $125M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $81M
Short Term Investments $276M
Other Current Assets $10M
Other Non Current Assets -
Total Liabilities $50M
Total Current Liabilities $29M
Current Accounts Payable $4.4M
Deferred Revenue -
Current Debt -
Short Term Debt $5.6M
Total Non Current Liabilities $21M
Capital Lease Obligations $25M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $25M
Other Current Liabilities $19M
Other Non Current Liabilities $193K
Total Shareholder Equity $511M
Treasury Stock -
Retained Earnings -$576M
Common Stock $5K
Common Stock Shares Outstanding $54M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$135M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $6.7M
Capital Expenditures $3.8M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$302M
Cashflow From Financing $337M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$161M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $37K
Total Revenue $37K
Cost Of Revenue $6.7M
Costof Goods And Services Sold $6.7M
Operating Income -$188M
Selling General And Administrative $47M
Research And Development $141M
Operating Expenses $188M
Investment Income Net -
Net Interest Income $27M
Interest Income $27M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.7M
Income Before Tax -$161M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$161M
Comprehensive Income Net Of Tax -
Ebit -$195M
Ebitda -$188M
Net Income -$161M

FDMT News

FDMT Profile

4D Molecular Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company headquartered in Emeryville, California, dedicated to pioneering advanced therapeutics using its proprietary adeno-associated virus (AAV) vector platform. The company is at the forefront of addressing critical unmet medical needs in ophthalmology, neurology, and rare diseases, with a strong focus on transforming patient outcomes through innovative gene therapies. With a well-developed pipeline and strategic collaborations, 4D Molecular Therapeutics is strategically positioned to lead advancements in the biotherapeutics sector, aiming to bring novel treatments to market and establish itself as a prominent player in the field.

VHAI
-25.00%
$0.00
RANI
+248.26%
$1.64
BYND
+24.15%
$0.64
YYAI
+0.83%
$0.12
YDKG
-40.50%
$0.05
CGBS
-39.47%
$0.03
BITF
-5.11%
$5.01
NVDA
+0.77%
$183.22
INTC
+0.46%
$37.01
RGTI
-3.31%
$46.38
GDXD
+20.23%
$0.72
F
+1.53%
$11.92
PLUG
-2.29%
$3.40
ARTV
+116.96%
$6.01
BURU
+0.85%
$0.34
TSLA
+2.46%
$439.31
DNN
-5.50%
$2.92
BBD
+1.22%
$3.30
IONZ
+7.55%
$3.70
HBAN
+0.84%
$15.50
NIO
-1.17%
$6.75
CAN
-4.19%
$1.60
NVTS
-6.20%
$14.66
HIMS
-15.84%
$49.78
RXRX
-7.86%
$5.86
TLRY
+1.29%
$1.56
AXDX
-61.36%
$0.03
BTG
-6.56%
$5.55
HPE
+2.04%
$22.96
LAES
+4.87%
$6.67
RGTZ
+6.58%
$11.97
T
+0.53%
$26.34
ETHD
+2.25%
$4.09
ELBM
+35.36%
$2.22
BLMZ
-3.85%
$0.18
ACHR
-5.30%
$11.24
AMD
-0.63%
$233.08
WTO
-47.99%
$0.07
CIFR
+0.21%
$18.76
KVUE
+8.36%
$15.29
GNPX
-23.68%
$0.36
LNKS
+30.35%
$0.73
RIG
+0.92%
$3.26
GPUS
-11.96%
$0.32
MARA
-3.42%
$19.57
AAPL
+1.95%
$252.29
BAC
+1.66%
$51.28
SOFI
-0.22%
$26.54
JOBY
-2.55%
$15.66
SOUN
-8.38%
$19.02
RF
+0.98%
$23.58
AMZN
-0.66%
$213.04
QBTS
-5.26%
$38.33
PLTR
+0.01%
$178.15
EPWK
-18.45%
$0.07
ONDS
-7.19%
$7.61
GRAB
-1.22%
$5.64
QUBT
-2.18%
$18.32
ADAP
+2.51%
$0.20
PFE
+1.15%
$24.51
RMBL
+60.50%
$3.21
SLB
-0.88%
$32.63
BMNR
-2.40%
$49.85
ABEV
+0.89%
$2.25
IREN
-1.79%
$60.72
ASST
-7.28%
$0.83
ADD
-25.47%
$0.05
SNAP
-1.41%
$7.65
ORCL
-6.92%
$291.31
CRML
+7.41%
$20.86
DFLI
+2.25%
$1.36
BTBT
-1.08%
$3.65
SRM
+53.27%
$10.30
AAL
-0.25%
$11.86
NUAI
+44.44%
$4.55
NEHC
+44.44%
$4.55
IONQ
-4.04%
$62.94
WULF
+0.50%
$13.93
NAK
-8.48%
$2.04
NOK
+1.05%
$5.74
ATAI
+17.70%
$6.45
RR
-4.05%
$5.44
SMR
-7.11%
$44.25
CLSK
-2.32%
$19.52
GWH
+16.04%
$5.28
APLD
-6.55%
$34.24
CRWV
-3.43%
$136.87
QS
-0.64%
$15.36
GOOGL
+0.73%
$253.30
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
UUUU
-2.90%
$21.06
VALE
-0.09%
$11.10
WLGS
-5.57%
$0.04
FNB
+3.00%
$15.09
BULL
-6.29%
$11.01
WOK
-31.91%
$0.03
AG
-8.51%
$14.02
VIVK
-29.17%
$0.20
LBRT
+28.30%
$15.32
VHAI
-25.00%
$0.00
RANI
+248.26%
$1.64
BYND
+24.15%
$0.64
YYAI
+0.83%
$0.12
YDKG
-40.50%
$0.05
CGBS
-39.47%
$0.03
BITF
-5.11%
$5.01
NVDA
+0.77%
$183.22
INTC
+0.46%
$37.01
RGTI
-3.31%
$46.38
GDXD
+20.23%
$0.72
F
+1.53%
$11.92
PLUG
-2.29%
$3.40
ARTV
+116.96%
$6.01
BURU
+0.85%
$0.34
TSLA
+2.46%
$439.31
DNN
-5.50%
$2.92
BBD
+1.22%
$3.30
IONZ
+7.55%
$3.70
HBAN
+0.84%
$15.50
NIO
-1.17%
$6.75
CAN
-4.19%
$1.60
NVTS
-6.20%
$14.66
HIMS
-15.84%
$49.78
RXRX
-7.86%
$5.86
TLRY
+1.29%
$1.56
AXDX
-61.36%
$0.03
BTG
-6.56%
$5.55
HPE
+2.04%
$22.96
LAES
+4.87%
$6.67
RGTZ
+6.58%
$11.97
T
+0.53%
$26.34
ETHD
+2.25%
$4.09
ELBM
+35.36%
$2.22
BLMZ
-3.85%
$0.18
ACHR
-5.30%
$11.24
AMD
-0.63%
$233.08
WTO
-47.99%
$0.07
CIFR
+0.21%
$18.76
KVUE
+8.36%
$15.29
GNPX
-23.68%
$0.36
LNKS
+30.35%
$0.73
RIG
+0.92%
$3.26
GPUS
-11.96%
$0.32
MARA
-3.42%
$19.57
AAPL
+1.95%
$252.29
BAC
+1.66%
$51.28
SOFI
-0.22%
$26.54
JOBY
-2.55%
$15.66
SOUN
-8.38%
$19.02
RF
+0.98%
$23.58
AMZN
-0.66%
$213.04
QBTS
-5.26%
$38.33
PLTR
+0.01%
$178.15
EPWK
-18.45%
$0.07
ONDS
-7.19%
$7.61
GRAB
-1.22%
$5.64
QUBT
-2.18%
$18.32
ADAP
+2.51%
$0.20
PFE
+1.15%
$24.51
RMBL
+60.50%
$3.21
SLB
-0.88%
$32.63
BMNR
-2.40%
$49.85
ABEV
+0.89%
$2.25
IREN
-1.79%
$60.72
ASST
-7.28%
$0.83
ADD
-25.47%
$0.05
SNAP
-1.41%
$7.65
ORCL
-6.92%
$291.31
CRML
+7.41%
$20.86
DFLI
+2.25%
$1.36
BTBT
-1.08%
$3.65
SRM
+53.27%
$10.30
AAL
-0.25%
$11.86
NUAI
+44.44%
$4.55
NEHC
+44.44%
$4.55
IONQ
-4.04%
$62.94
WULF
+0.50%
$13.93
NAK
-8.48%
$2.04
NOK
+1.05%
$5.74
ATAI
+17.70%
$6.45
RR
-4.05%
$5.44
SMR
-7.11%
$44.25
CLSK
-2.32%
$19.52
GWH
+16.04%
$5.28
APLD
-6.55%
$34.24
CRWV
-3.43%
$136.87
QS
-0.64%
$15.36
GOOGL
+0.73%
$253.30
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
UUUU
-2.90%
$21.06
VALE
-0.09%
$11.10
WLGS
-5.57%
$0.04
FNB
+3.00%
$15.09
BULL
-6.29%
$11.01
WOK
-31.91%
$0.03
AG
-8.51%
$14.02
VIVK
-29.17%
$0.20
LBRT
+28.30%
$15.32
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.